LABATE, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 3.481
AS - Asia 1.694
EU - Europa 1.486
SA - Sud America 183
AF - Africa 26
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.895
Nazione #
US - Stati Uniti d'America 3.359
SG - Singapore 1.192
IT - Italia 583
CN - Cina 267
SE - Svezia 232
GB - Regno Unito 183
DE - Germania 151
BR - Brasile 143
CA - Canada 104
HK - Hong Kong 93
EE - Estonia 91
FI - Finlandia 57
IN - India 55
RU - Federazione Russa 51
RO - Romania 28
NL - Olanda 23
JP - Giappone 19
AU - Australia 17
MX - Messico 16
ZA - Sudafrica 15
FR - Francia 14
CO - Colombia 13
PL - Polonia 12
IQ - Iraq 11
UA - Ucraina 11
BD - Bangladesh 10
TR - Turchia 9
ES - Italia 8
AR - Argentina 7
SA - Arabia Saudita 7
CH - Svizzera 6
CL - Cile 6
AT - Austria 5
CZ - Repubblica Ceca 5
IR - Iran 5
VN - Vietnam 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EC - Ecuador 4
IE - Irlanda 4
MA - Marocco 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BG - Bulgaria 3
GR - Grecia 3
JO - Giordania 3
KR - Corea 3
MK - Macedonia 3
PE - Perù 3
PK - Pakistan 3
EU - Europa 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
KW - Kuwait 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TO - Tonga 1
UY - Uruguay 1
Totale 6.895
Città #
Chandler 660
Singapore 547
Santa Clara 279
Milan 225
Princeton 221
Lawrence 220
London 147
Chicago 139
Wilmington 115
Munich 109
Hong Kong 89
Des Moines 80
Ashburn 78
Ottawa 75
Boardman 59
Turku 42
Catanzaro 40
Los Angeles 39
Shanghai 37
The Dalles 26
Guangzhou 25
Rome 22
New York 21
Pune 19
Redwood City 19
Columbus 16
Norwalk 16
Redmond 16
Helsinki 15
San Francisco 15
Brooklyn 14
Council Bluffs 14
Naples 14
São Paulo 14
Beijing 13
Chennai 11
Mexico City 11
Charlotte 10
Seattle 10
Shenzhen 10
Tokyo 10
Warsaw 10
Amsterdam 9
Augusta 9
Johannesburg 9
Timisoara 9
Atlanta 8
Falls Church 8
Horia 8
St Petersburg 8
Stockholm 8
Toronto 8
Buffalo 7
Casalnuovo Di Napoli 7
Dallas 7
Florence 7
Melbourne 7
Montreal 7
Boston 6
Hefei 6
San Nicola Manfredi 6
Bethesda 5
Castiglion Fibocchi 5
Denver 5
Hanover 5
Miami 5
Moscow 5
Paris 5
Rui'an 5
Taranto 5
Valmadrera 5
Wuhan 5
Wuxi 5
Xuzhou 5
Assago 4
Aversa 4
Basra 4
Berlin 4
Bologna 4
Carrara 4
Catania 4
Cetraro 4
Falerna 4
Gatchina 4
Genoa 4
Las Vegas 4
Phoenix 4
Reggio Calabria 4
Rimini 4
San Jose 4
Treviso 4
Uberlândia 4
Washington 4
Wuhu 4
Xi'an 4
Amman 3
Ann Arbor 3
Cagliari 3
Clearwater 3
Crotone 3
Totale 3.860
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 149
Genetics of reflex seizures and epilepsies in humans and animals 127
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 119
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 111
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 77
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study 71
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 65
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 64
Neocortical thinning in “benign” mesial temporal lobe epilepsy 62
Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. 53
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 51
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 47
Long-term outcome of mild mesial temporal lobe epilepsy 46
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 46
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 45
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 44
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 43
A puzzling case without solution: isolated late-onset epileptic seizure 41
Teaching NeuroImages: Pseudohypertrophic cerebral cortex in end-stage Creutzfeldt-Jakob disease 41
Age at onset predicts good seizure outcome in sporadic non-lesional and mesial temporal sclerosis based temporal lobe epilepsy 41
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 41
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 40
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 40
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 40
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 40
Neuropsychological profile of mild temporal lobe epilepsy 39
A new Italian instrument for the assessment of irritability in patients with epilepsy. 39
Structural brain abnormalities in the common epilepsies assessed in 3,876 individuals worldwide 39
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 39
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 39
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 39
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 39
Why should we change the term psychogenic nonepileptic seizures (PNES)? 38
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 38
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 38
Psychopathological constellation in Psychogenic Non-Epileptic Seizures 38
Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy. 37
Gerstmann-Straussler-Scheinker disease with PRNP P102L heterozygous mutation presenting as progressive myoclonus epilepsy. 37
Diagnostic Biomarkers of Epilepsy 37
A novel mutation in the notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and MRI spectroscopic analyses 36
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy 35
Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study 35
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 34
Association between the M129V variant allele of PRNP gene and mild temporal lobe epilepsy in women 34
Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness 34
Reversible symmetrical external capsule hyperintensity as an early finding of autoimmune encephalitis. 34
White Matter Abnormalities Differentiate Severe from Benign Temporal Lobe Epilepsy. 34
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 34
Brand-to-Generic Levetiracetam Switching: a four-years prospective observational real-life study 34
Functional activity changes in memory and emotional systems of healthy subjects with déjà vu. 34
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 34
Value of multimodal imaging approach to diagnosis of neurosarcoidosis 34
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 34
Spontaneous obliteration of MRI-silent cerebral angiomatosis revealed by CT angiography in a patient with Sturge-Weber syndrome 33
Mild Lafora disease: Clinical, neurophysiologic, and genetic findings. 33
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features. 33
The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study 33
Permutation entropy of scalp EEG: A tool to investigate epilepsies: Suggestions from absence epilepsies. 32
Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report 32
Modeling epileptogenic lesions and mapping networks - Imaging genetics for benign mesial temporal lobe epilepsy 32
Brainstem Posterior Reversible Encephalopathy Syndrome in an Asymptomatic Patient. 32
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 31
Cerebral venous thrombosis and isolated intracrania hypertension without papilledema in CDH 31
Why should we change the term psychogenic nonepileptic seizures? 31
Prodynorphin gene promoter polymorphism and temporal lobe epilepsy 31
Advanced MRI Morphologic Study Shows No Atrophy in Healthy Individuals with Hippocampal Hyperintensity 31
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures 31
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 31
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis 31
Deep learning representation from electroencephalography of early-stage creutzfeldt-jakob disease and features for differentiation from rapidly progressive dementia 31
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17458 subjects 31
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study 31
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study 31
Familial mesial temporal lobe epilepsy (FMTLE): a clinical and genetic study of 15 Italian families 30
Familial mesial temporal lobe epilepsies: clinical and genetic features 30
The meaning of anxiety in patients with PNES. 30
Value of clinical features to differentiate refractory epilepsy from mimics: a prospective longitudinal cohort study. 30
Detection of hippocampal atrophy in patients with temporal lobe epilepsy: a 3-Tesla MRI shape. 30
Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy 30
Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals 30
Tremor pattern differentiates drug-induced resting tremor from Parkinson disease. 30
Profile of brivaracetam and its potential in the treatment of epilepsy 30
Corrigendum to “Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study” [Epilepsy Behav 74 (2017) Pages 69–72] 30
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 29
Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectives 29
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy. Manna I, Gambardella A, Labate A, Mumoli L, Ferlazzo E, Pucci F, Aguglia U, Quattrone A. Seizure. 2015 Jan;24:124-6. 29
Neuroanatomic correlates of psychogenic nonepileptic seizures: A cortical thickness and VBM study. 29
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 29
Blocking out the real diagnosis 29
GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy 29
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 29
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording 29
An SNP site in pri-miR-124, a brain expressed miRNA gene, no contribution to mesial temporal lobe epilepsy in an Italian sample. 29
The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study 28
Hepatonecrosis and cholangitis related to long-term phenobarbital therapy: An autopsy report of two patients 28
Hypersomnia hiding a bipolar disorder 28
Homozygous c.649dupC mutation in PRRT2 worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absences. 28
Preoperative non invasive electrophysiological evaluation and neuroradiological examination in epilepsy surgery 28
The parkin gene is not involved in late-onset Parkinson’s disease 28
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study 28
Totale 3.978
Categoria #
all - tutte 99.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 10 5 5 31 26 14 7 25 72 27 13 5
2021/2022667 14 1 0 173 66 13 13 133 81 63 105 5
2022/20231.786 448 94 44 202 207 175 4 110 271 102 107 22
2023/2024836 167 120 85 51 56 191 18 31 9 17 26 65
2024/20253.113 366 218 169 146 212 410 129 94 354 222 267 526
2025/2026312 312 0 0 0 0 0 0 0 0 0 0 0
Totale 7.126